Collaboration will develop phenotypic personalized medicine platform for cancer patients

IntelliCyt (Albuquerque, NM), which develops integrated platforms that accelerate drug discovery, antibody discovery, and immuno-oncology research, is collaborating with Notable Labs (San Francisco, CA) to further the development of a predictive personalized medicine platform. The two companies recognize that next-generation platforms must integrate immune profiling in physiologically relevant ex vivo microenvironments (cancer patient cells, in this case) to ensure clinical translation of laboratory results.

Related: Fluorescing engineered DNA promises personalized cancer therapy

Notable Labs helps oncologists identify effective therapies that they can prescribe by testing them on a patient's own cells. This approach promises tailored treatment options fast enough for doctors to put to use. By testing a broad set of drugs and drug combinations, the company is able to functionally profile cancer cells, which leads to a better understanding of the biological mechanisms of the patient's cancer. Providing this information to physicians can improve treatment outcomes while reducing side effects.

Notable Labs will use IntelliCyt's iQue Screener PLUS platform in a fully automated, high-throughput laboratory to immune-profile phenotypic and functional endpoints of cells and secreted proteins through cell- and bead-based assays. Prioritized treatment options will be highlighted in reports to clinicians using Notable Lab's screening process with IntelliCyt's immune-profiling technology.

The platform, which integrates an instrument, software and reagent system, offers a proprietary high-throughput sampling capability that enables the rapid assessment of cells and beads in suspension in 96-, 384-, and 1536-well plates. Miniaturization of the assay is possible to save reagent cost and conserve samples, and high-content, multiplex readouts are generated on each individual cell or bead via the flow cytometry-based detection system.

For more information, please visit www.intellicyt.com and www.notablelabs.com.

Get All the BioOptics World News Delivered to Your Inbox

Subscribe to BioOptics World Magazine or email newsletter today at no cost and receive the latest news and information.

 Subscribe Now
Related Articles

Shortwave-infrared device could improve ear infection diagnosis

An otoscope-like device that could improve ear infection diagnosis uses shortwave-infrared light instead of visible light.

Microscope detects one million-plus biomarkers for sepsis in 30 minutes

A microscope has the potential to simultaneously detect more than one million biomarkers for sepsis at the point of care.

Eye test that pairs two in vivo imaging methods may detect Parkinson's earlier

A low-cost, noninvasive eye test pairs two in vivo imaging methods to help detect Parkinson's before clinical symptoms appear.

Fluorescence microscopy helps provide new insight into how cancer cells metastasize

By using fluorescence microscopy, scientists have discovered an alternate theory on how some cancer cells metastasize.

BLOGS

Neuro15 exhibitors meet exacting demands: Part 2

Increasingly, neuroscientists are working with researchers in disciplines such as chemistry and p...

Why be free?

A successful career contributed to keeping OpticalRayTracer—an optical design software program—fr...

LASER Munich 2015 is bio-bent

LASER World of Photonics 2015 included the European Conferences on Biomedical Optics among its si...

White Papers

Understanding Optical Filters

Optical filters can be used to attenuate or enhance an image, transmit or reflect specific wavele...

How can I find the right digital camera for my microscopy application?

Nowadays, image processing is found in a wide range of optical microscopy applications. Examples ...

CONNECT WITH US

            

Twitter- BioOptics World